Literature DB >> 8346860

Administration errors with a conventional metered dose inhaler versus a novel breath actuated device.

J S Larsen1, M Hahn, J W Kochevar, R J Morris, H B Kaiser, S C Weisberg, P C Halverson, S N Quessy.   

Abstract

Metered dose inhalers are difficult for patients to use. A device that eliminates coordination and timing of actuation may simplify the use of metered dose inhalers. This trial compared (1) number of errors made and (2) specific errors made between the conventional press and breathe metered dose inhaler (MDI) and the novel breath actuated Autohaler inhalation device in 24 subjects. We studied the use of each device in 12 patients trained and experienced in using an MDI and in 12 volunteers who had never been exposed to any inhalation device. We observed that even experienced patients continue to have difficulty with the coordination and timing of metered dose inhalers. The volunteer group had equal difficulty with both devices but it appeared that it was easier for them to learn how to use the breath actuated device than the MDI.

Entities:  

Mesh:

Year:  1993        PMID: 8346860

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  3 in total

Review 1.  Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma.

Authors:  J C Adkins; R N Brogden
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

2.  Evaluating the outcome of two teaching methods of breath actuated inhaler in an inner city asthma clinic.

Authors:  R J Rydman; K Sonenthal; L Tadimeti; N Butki; M F McDermott
Journal:  J Med Syst       Date:  1999-10       Impact factor: 4.460

Review 3.  A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease.

Authors:  Frank Kässner; Rick Hodder; Eric D Bateman
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.